Federal Funding for Health Security in FY2018
Overview
Affiliations
This article is the latest in an annual series analyzing federal funding for health security programs. It examines proposed funding in the President's Budget Request for FY2018 and provides updated amounts for FY2017 and actual funding for FY2010 through FY2016. The proposed FY2018 budget for health security-related programs represents a significant decrease in funding from prior years and previous administrations. In total, the President's proposed FY2018 budget includes $12.45 billion for health security-related programs, an estimated decrease in funding of $1.25 billion, or 9%, from the estimated $13.71 billion in FY2017 and an 11% decrease from the FY2016 actual funding level of $13.99 billion. Most FY2018 health security funding ($6.67 billion, 54%) would go to programs with multiple-hazard and preparedness goals and missions, representing a 14% decrease in this funding compared to FY2017. Radiological and nuclear security programs would receive 20% ($2.48 billion) of all health security funding, a slight decrease of 2% from the prior year. Biosecurity programs would be funded at $1.53 billion (12% of health security funding) in FY2018, a decrease of 6% compared to FY2017. Chemical security programs would represent 3% ($389.7 million) of all health security funding in FY2018, a 9% decrease from the prior year. Finally, 11% of health security funding ($1.39 billion) would be dedicated to pandemic influenza and emerging infectious diseases programs, the only category of funding to see an increase (3%) above FY2017.
A Public Health Systems View of Risk Communication About Zika.
Sell T, Ravi S, Watson C, Meyer D, Pechta L, Rose D Public Health Rep. 2020; 135(3):343-353.
PMID: 32243762 PMC: 7238702. DOI: 10.1177/0033354920912215.
A Critical Analysis of the Scientific and Commercial Rationales for the Synthesis of Horsepox Virus.
Koblentz G mSphere. 2018; 3(2).
PMID: 29569633 PMC: 5853483. DOI: 10.1128/mSphere.00040-18.
Jang D, Khatri U, Mudan A, Love J, Owiredu S, Eckmann D J Med Toxicol. 2018; 14(2):144-151.
PMID: 29536431 PMC: 5962467. DOI: 10.1007/s13181-018-0656-6.